Indix Sr (Indapamide)

Indapamide blocks the sodium‑chloride cotransporter in the distal convoluted tubule of the kidney, decreasing reabsorption of these ions. This promotes water excretion, lowers plasma volume, and reduces peripheral vascular resistance, which together help control blood pressure and diminish edema.

The appropriate dose of Indix Sr is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The pregnancy category for indapamide is not clearly defined. It should only be used during pregnancy or lactation when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and after consultation with a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Indapamide shares the same thiazide‑like mechanism as hydrochlorothiazide but generally provides a longer duration of action and may have a more favorable metabolic profile, with less impact on blood glucose and lipid levels. Choice between agents depends on individual patient factors and clinician preference.

Indix Sr tablets should be stored below 25 °C in a dry place, kept in the original container, and protected from moisture and direct sunlight. Do not store in the bathroom or near heat sources, and keep out of reach of children.

Indix Sr is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should follow the specific instructions given by their prescriber to ensure consistent absorption and effect.

The most serious risks include severe dehydration, significant electrolyte disturbances such as hyponatremia or hypokalemia, acute kidney injury, and rare allergic reactions. Patients should be monitored for signs of these conditions, especially during the initial weeks of therapy.

Indix Sr is contraindicated in individuals with anuria, severe renal impairment, known hypersensitivity to indapamide or other sulfonamide drugs, and in patients with severe hepatic disease. It should also be used with caution in those with gout or a history of electrolyte abnormalities.